Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A known ✓ | Q15858 | 1/20 | 0.32 |
| ▸ | LTB4R | Q15722 | 3/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
| ▸ | ALPL | P05186 | 1/20 | 0.31 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.30 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.30 |
| ▸ | UCHL5 | Q9Y5K5 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1784625 | 0.99 | LTB4R (0.35) | LTB4RAOC3SCN9AALPLUCHL1 | |
| SCHEMBL18112561 | 0.88 | CYP19A1 (0.36) | LTB4RAOC3MEN1ALDH1A1GAA | |
| SCHEMBL13997750 | 0.87 | LTB4R (0.41) | LTB4RAOC3SCN9AALPLUCHL1 | |
| SCHEMBL9594349 | 0.87 | LTB4R (0.41) | LTB4RAOC3SCN9AALPLUCHL1 | |
| SCHEMBL18112512 | 0.86 | CYP19A1 (0.35) | LTB4RAOC3MEN1ALDH1A1GAA | |
| SCHEMBL9296643 | 0.82 | LTB4R (0.41) | LTB4RAOC3ALPLUCHL1UCHL3 | |
| SCHEMBL1786817 | 0.81 | CNR1 (0.34) | SCN9AHSD17B10 | |
| SCHEMBL8755383 | 0.81 | ALDH1A1 (0.40) | LTB4RAOC3MEN1NPC1ALDH1A1 | |
| SCHEMBL1782379 | 0.81 | ALDH1A1 (0.33) | AOC3MEN1NPC1ALDH1A1MAPT | |
| SCHEMBL7199262 | 0.79 | TXN (0.39) | MEN1ALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4741825-A1 | TEST KIT | Lifetrek Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-20260063554-A1 | METHODS AND SYSTEMS FOR TIME-GATED FLUORESCENT-BASED DETECTION | INSILIXA INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-20250231112-A1 | METHODS AND SYSTEMS FOR TIME-GATED FLUORESCENT-BASED DETECTION | INSILIXA, INC. | 2025-07-17 | — | — | US | disclosed |
| US-20250216331-A1 | OPTICAL MEASUREMENT DEVICE AND OPTICAL MEASUREMENT METHOD | HAMAMATSU PHOTONICS K.K. (JP) | 2025-07-03 | — | — | US | disclosed |
| US-12305097-B2 | Fluorescent silica nanoparticles using silane-lanthanum-base complex composite and cross-linking reaction and method for manufacturing same | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2025-05-20 | — | — | US | disclosed |
| US-12287288-B2 | Optical measurement device and optical measurement method | HAMAMATSU PHOTONICS K.K. (JP) | 2025-04-29 | — | — | US | disclosed |
| US-20250067734-A1 | Fluorescent Cellulose Particles | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-02-27 | — | — | US | disclosed |
| CN-119510370-A | Method and system for fluorescence detection based on time gating | 因斯利克萨公司 | 2025-02-25 | — | — | CN | disclosed |
| WO-2025013724-A1 | TEST KIT | ライフトレック株式会社 | 2025-01-16 | — | — | WO | disclosed |
| CN-113924041-B | Method and system for fluorescence detection based on time gating | 因斯利克萨公司 | 2024-12-03 | — | — | CN | disclosed |
| US-20220276256-A1 | METHODS FOR DETECTING ASSAY INTERFERENTS AND INCREASING DYNAMIC RANGE | ABBOTT LABORATORIES | 2022-09-01 | — | — | US | disclosed |
| WO-2022163124-A1 | MEMBRANE FOR IMMUNOCHROMATOGRAPHIC ASSAYS, TEST STRIP FOR IMMUNOCHROMATOGRAPHIC ASSAYS, AND TEST METHOD | 東洋濾紙株式会社 | 2022-08-04 | — | — | WO | disclosed |
| US-11371987-B2 | Method of amplifying detection light using light-reflecting material, in immunochromatography | DENKA COMPANY LIMITED (JP) | 2022-06-28 | — | — | US | disclosed |
| EP-4010707-A1 | METHODS FOR DETECTING ASSAY INTERFERENTS AND INCREASING DYNAMIC RANGE | Abbott Laboratories (US) | 2022-06-15 | — | — | EP | disclosed |
| US-11360029-B2 | Methods and systems for time-gated fluorescent-based detection | INSILIXA, INC. (US) | 2022-06-14 | — | — | US | disclosed |
| US-20220151962-A1 | NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2022-05-19 | — | — | US | disclosed |
| WO-2022037599-A9 | CHLORIN DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, USE THEREOF, AND COMBINATION THEREOF WITH ULTRASOUND MEDICAL SYSTEM | 广州易斯生物科技发展有限公司 | 2022-04-21 | — | — | WO | disclosed |
| WO-2022037599-A1 | CHLORIN DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, USE THEREOF, AND COMBINATION THEREOF WITH ULTRASOUND MEDICAL SYSTEM | 广州易斯生物科技发展有限公司 | 2022-02-24 | — | — | WO | disclosed |
| US-20220054636-A1 | Chlorin Derivatives or Pharmaceutically Acceptable Salts Thereof, Preparation Method and Use Thereof, and Combination Thereof with an Ultrasonic Medical System | GUANGZHOU EEC BIOTECH DEVELOPMENT CO., LTD. (CN) | 2022-02-24 | — | — | US | disclosed |
| EP-3941900-A1 | NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 | Deutsches Krebsforschungszentrum (DE) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220151962-A1 | NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 | HDAC10, HDAC1, HDAC11 | SCN9A 1326/4885LTB4R 4595/4885AOC3 3159/4885 |
| US-20220054636-A1 | Chlorin Derivatives or Pharmaceutically Acceptable Salts Thereof, Preparation Method and Use Thereof, and Combination Thereof with an Ultrasonic Medical System | STAT6, JAK3, JAK1 | SCN9A 4588/4885LTB4R 4708/4885AOC3 1956/4885 |
| US-20260063554-A1 | METHODS AND SYSTEMS FOR TIME-GATED FLUORESCENT-BASED DETECTION | NT5C2, PER2, RYR2 | SCN9A 861/4885LTB4R 3315/4885AOC3 3580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.